0.8597 USD
-0.01 (-0.88%)
Taking everything into account, CBAT scores 3 out of 10 in our fundamental rating. CBAT was compared to 91 industry peers in the Electrical Equipment industry. CBAT has a bad profitability rating. Also its financial health evaluation is rather negative. CBAT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CBAT had negative earnings in the past year.
- In the past year CBAT had a positive cash flow from operations.
- In multiple years CBAT reported negative net income over the last 5 years.
- In multiple years CBAT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- CBAT has a Return On Assets of -1.79%. This is in the better half of the industry: CBAT outperforms 62.64% of its industry peers.
- CBAT has a better Return On Equity (-5.36%) than 63.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.79% | ||
| ROE | -5.36% | ||
| ROIC | N/A |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CBAT's Profit Margin has declined in the last couple of years.
- CBAT's Gross Margin of 14.07% is on the low side compared to the rest of the industry. CBAT is outperformed by 64.84% of its industry peers.
- In the last couple of years the Gross Margin of CBAT has grown nicely.
- The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 14.07% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
2. Health
2.1 Basic Checks
- CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CBAT has about the same amount of shares outstanding.
- Compared to 5 years ago, CBAT has more shares outstanding
- The debt/assets ratio for CBAT has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -0.17, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of CBAT (-0.17) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.29 indicates that CBAT is not too dependend on debt financing.
- The Debt to Equity ratio of CBAT (0.29) is better than 60.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.17 |
ROIC/WACCN/A
WACC5.73%
2.3 Liquidity
- A Current Ratio of 0.69 indicates that CBAT may have some problems paying its short term obligations.
- With a Current ratio value of 0.69, CBAT is not doing good in the industry: 82.42% of the companies in the same industry are doing better.
- CBAT has a Quick Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.54, CBAT is doing worse than 78.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.69 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
- The earnings per share for CBAT have decreased strongly by -141.18% in the last year.
- Measured over the past years, CBAT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -42.83% on average per year.
- Looking at the last year, CBAT shows a very negative growth in Revenue. The Revenue has decreased by -22.02% in the last year.
- The Revenue has been growing by 51.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
3.2 Future
- The Earnings Per Share is expected to decrease by -11.42% on average over the next years. This is quite bad
- The Revenue is expected to grow by 30.48% on average over the next years. This is a very strong growth
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- CBAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Based on the Price/Forward Earnings ratio of 8.43, the valuation of CBAT can be described as reasonable.
- 97.80% of the companies in the same industry are more expensive than CBAT, based on the Price/Forward Earnings ratio.
- CBAT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.43 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- CBAT's earnings are expected to decrease with -11.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CBAT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CBAT (1/16/2026, 2:15:25 PM)
0.8597
-0.01 (-0.88%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-16 2026-03-16/bmo
Inst Owners2.7%
Inst Owner Change0%
Ins Owners5.56%
Ins Owner Change0%
Market Cap76.21M
Revenue(TTM)161.76M
Net Income(TTM)-6.51M
Analysts0
Price Target1.53 (77.97%)
Short Float %0.22%
Short Ratio0.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)26.47%
Max EPS beat(2)173.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)35.26%
Min Revenue beat(2)18.4%
Max Revenue beat(2)52.11%
Revenue beat(4)2
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)52.11%
Revenue beat(8)2
Avg Revenue beat(8)-9.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)58.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)53.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)28.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.43 | ||
| P/S | 0.47 | ||
| P/FCF | N/A | ||
| P/OCF | 2.68 | ||
| P/B | 0.63 | ||
| P/tB | 0.63 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.07
EYN/A
EPS(NY)0.1
Fwd EY11.86%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.32
OCFY37.33%
SpS1.82
BVpS1.37
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.79% | ||
| ROE | -5.36% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 14.07% | ||
| FCFM | N/A |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 509.98% | ||
| Cap/Sales | 22.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.69 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | -0.17 |
F-Score2
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-149.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.57%
OCF growth 3YN/A
OCF growth 5YN/A
CBAK ENERGY TECHNOLOGY INC / CBAT FAQ
What is the fundamental rating for CBAT stock?
ChartMill assigns a fundamental rating of 3 / 10 to CBAT.
What is the valuation status of CBAK ENERGY TECHNOLOGY INC (CBAT) stock?
ChartMill assigns a valuation rating of 2 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.
How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?
CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.
Can you provide the financial health for CBAT stock?
The financial health rating of CBAK ENERGY TECHNOLOGY INC (CBAT) is 2 / 10.